Key result
The zero-fluoroscopy approach for catheter ablation of supraventricular tachycardia provided similar total success rates and complication rates compared to conventional fluoroscopy.
Why the study?
Three-dimensional electroanatomic mapping reduces radiation exposure, but the safety, feasibility, and efficacy of a completely zero-fluoroscopy approach for supraventricular tachycardia ablation using Ensite NavX compared to conventional fluoroscopy needed investigation.
Does a completely zero-fluoroscopy approach using the Ensite NavX system maintain safety and efficacy compared to conventional fluoroscopy in patients undergoing catheter ablation for supraventricular tachycardia?
Cohort (n=3,060)
Yes
Does a completely zero-fluoroscopy approach using the Ensite NavX system maintain safety and efficacy compared to conventional fluoroscopy in patients undergoing catheter ablation for supraventricular tachycardia?
A completely zero-fluoroscopy approach for SVT ablation using 3D mapping is as safe and effective as conventional fluoroscopy while eliminating radiation exposure for patients and operators.
Answers are grounded in this paper and cite their sources.
May support zero-fluoroscopy SVT ablation as radiation-sparing option; leaves open confirmation in randomized trials.
BACKGROUND: Three-dimensional electroanatomic mapping systems have demonstrated a significant reduction in radiation exposure during radiofrequency catheter ablation procedures. We aimed to investigate the safety, feasibility and efficacy of a completely zero-fluoroscopy approach for catheter ablation of supraventricular tachycardia using the Ensite NavX navigation system compared with a conventional fluoroscopy approach. METHODS: A multicenter prospective non-randomized registry study was performed in seven centers from January 2013 to February 2018. Consecutive patients referred for catheter ablation of supraventricular tachycardia were assigned either to a completely zero-fluoroscopic approach (ZF) or conventional fluoroscopy approach (CF) according to the operator's preference. Patients with atrial tachycardia were excluded. RESULTS: Totally, 1020 patients were enrolled in ZF group; 2040 patients ablated by CF approach were selected for controls. There was no significant difference between the zero-fluoroscopy group and conventional fluoroscopy group as to procedure time (60.3 ± 20.3 vs. 59.7 ± 22.6 min, P = 0.90), immediate success rate of procedure (98.8% vs. 99.2%, P = 0.22), arrhythmia recurrence (0.4% vs. 0.5%, P = 0.85), total success rate of procedure (98.4% vs. 98.8%, P = 0.39) or complications (1.1% vs. 1.5%, P = 0.41). Compared with the conventional fluoroscopy approach, the zero-fluoroscopy approach provided similar outcomes without compromising the safety or efficacy of the procedure. CONCLUSION: The completely zero-fluoroscopy approach demonstrated safety and efficacy comparable to a conventional fluoroscopy approach for catheter ablation of supraventricular tachycardia, and mitigated radiation exposure to both patients and operators. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT03042078; first registered February 3, 2017; retrospectively registered.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2020) conducted a cohort in Supraventricular tachycardia (n=3,060). Zero-fluoroscopy approach using the Ensite NavX system vs. Conventional fluoroscopy approach was evaluated on Total success rate of procedure (p=0.39). The zero-fluoroscopy approach for catheter ablation of supraventricular tachycardia provided similar total success rates and complication rates compared to conventional fluoroscopy.
Synapse has enriched 10 related papers. Consider them for comparative context: